Nivolumab + Ipilimumab Shows Improved Outcomes in MSI-H/dMMR mCRC CheckMate-8HW Trial ASCO GI 2 Mins Read Overview:The results from the Phase 3 CheckMate-8HW trial have just been released, demonstrating significant improvements in outcomes for patients with…
Phase 3 FRESCO-2 Trial Analysis of Fruquintinib mCRC Colorectal 3 Mins Read The phase 3 FRESCO-2 study evaluated the efficacy and safety of fruquintinib, a novel targeted therapy, in patients with advanced…
